Vice President, Head of Regulatory Affairs

Vice President, Head of Regulatory Affairs

About Zevra Therapeutics, Inc.

We are a rare disease therapeutics company leading with science to make life‑changing therapeutics available to patients with significant unmet needs. We involve key thought leaders, physicians, patients, care partners, and advocacy groups in all of our clinical and regulatory development strategies.

With a keen understanding that drug development often requires creative solutions, we have the insight and expertise to forge new pathways to success that others have missed. By following the data without bias, our transparent narratives and common‑sense perspective have successfully overcome complex development challenges to make much‑needed therapies available to patients.

Nimble and dauntless, we push boundaries beyond what is thought to be possible and advance new therapies that have the potential to bring meaningful improvement to patients’ lives.

The VP, Head of Regulatory Affairs is the company’s senior regulatory executive and a member of the leadership team. This leader owns the global regulatory strategy and execution across the portfolio consisting of commercial products and development assets. The VP of RA demonstrates exceptional leadership skills and a passion for fostering professional growth within their team as well as improving the internal processes in the department.

The role blends strategic leadership with hands‑on execution, suited to a lean organization.

• Define and continuously optimize global regulatory strategies (US/EU) for marketed and development programs.
• Collaborate with internal customers, SMEs and other partners/stakeholders to ensure regulatory risk is factored in business plans and decisions.
• Keep up‑to‑date, and be involved in the regulatory rare disease environment.
• Lead informed go/no‑go decisions cross‑functionally.
• Submissions & Approvals
• Own and direct major submissions and label negotiations.
• Ensure inspection readiness and submission quality.
• Prepare and lead Health Authority meetings and Advisory Committee meetings.
• Hands‑on execution of regulatory activities in cross‑functional collaboration.
• Post‑Approval & Lifecycle Management (Commercial Products)
• Set and execute LCM roadmap.
• Accountable for regulatory compliance activities to maintain Marketing Authorizations worldwide (periodic reporting, fee payment, safety reporting, promotional material, etc.).
• Support GxP compliance impacts on regulatory documentation, labeling and commitments.
• Development Programs (Clinical & CMC Integration)
• Anticipate and steer expedited pathways and special designations.
• Shape endpoints/COAs for rare diseases.
• Drive CMC readiness for pivotal/registration.
• Integrate patient voice and EAP/CUP considerations.
• Leadership & Organization
• Build and develop a high‑performing RA organization.
• Foster talent development and mentorship to cultivate future regulatory leaders.
• Establish operating rhythms and decision forums to ensure cross‑functional communication, timely decision‑making and tracking of progress.
• Set and manage budgets and vendor strategy.
• Governance, Quality & Systems
• Partner with QA on GxP compliance and inspection readiness.
• Own RA systems and documentation flows.
• Drive intelligence and policy monitoring.
• Advise Executive Team and Board on regulatory risk/mitigation.
• Ability to effectively communicate with internal customers, third‑party partners, and regulatory authorities.
• Represent the company externally at stakeholder meetings, conferences, and consortia.

• Required
• Advanced scientific degree or equivalent experience.
• 15+ years in Regulatory Affairs with significant rare‑disease expertise.
• Strong expertise in US/EU Regulatory Affairs in all drug stages from development to commercialization and experience with roll‑out to global markets.
• Demonstrated leadership of major submissions and successful HA engagements.
• Hands‑on experience integrating CMC, clinical, non‑clinical evidence.
• Strong team leadership in resource‑constrained settings.
• Proficiency with eCTD, RA publishing, and EDMS tools.
• Preferred
• Experience with EAP/CUP, RWE strategies, COA/endpoint development.
• Public speaking at AdComs or…